BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15097229)

  • 1. Optimizing global risk evaluation in primary hypertension: the role of microalbuminuria and cardiovascular ultrasonography.
    Viazzi F; Parodi D; Leoncini G; Vettoretti S; Ratto E; Vaccaro V; Ravera M; Tomolillo C; Bezante GP; Del Sette M; Deferrari G; Pontremoli R
    J Hypertens; 2004 May; 22(5):907-13. PubMed ID: 15097229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension.
    Viazzi F; Leoncini G; Parodi D; Ratto E; Vettoretti S; Vaccaro V; Parodi A; Falqui V; Tomolillo C; Deferrari G; Pontremoli R
    J Am Soc Nephrol; 2005 Mar; 16 Suppl 1():S89-91. PubMed ID: 15938043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal microvascular changes and target organ damage in untreated essential hypertensives.
    Cuspidi C; Meani S; Salerno M; Fusi V; Severgnini B; Valerio C; Catini E; Esposito A; Magrini F; Zanchetti A
    J Hypertens; 2004 Nov; 22(11):2095-102. PubMed ID: 15480092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach.
    Leoncini G; Sacchi G; Viazzi F; Ravera M; Parodi D; Ratto E; Vettoretti S; Tomolillo C; Deferrari G; Pontremoli R
    J Hypertens; 2002 Jul; 20(7):1315-21. PubMed ID: 12131528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of renal resistive index with target organ damage in essential hypertension.
    Doi Y; Iwashima Y; Yoshihara F; Kamide K; Takata H; Fujii T; Kubota Y; Nakamura S; Horio T; Kawano Y
    Am J Hypertens; 2012 Dec; 25(12):1292-8. PubMed ID: 22874890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Microalbuminuria in Patients of Essential Hypertension and its Correlation with Left Ventricular Hypertrophy and Carotid Artery Intima‑media Thickness.
    Pathak SR; Bhattarai N; Baskota D; Koju RP; Humagain S
    Kathmandu Univ Med J (KUMJ); 2022; 20(80):417-421. PubMed ID: 37795715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global risk stratification in primary hypertension: the role of the kidney.
    Leoncini G; Ratto E; Viazzi F; Conti N; Falqui V; Parodi A; Tomolillo C; Deferrari G; Pontremoli R
    J Hypertens; 2008 Mar; 26(3):427-32. PubMed ID: 18300851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular hypertrophy and cardiovascular risk stratification: impact and cost-effectiveness of echocardiography in recently diagnosed essential hypertensives.
    Cuspidi C; Meani S; Valerio C; Fusi V; Sala C; Zanchetti A
    J Hypertens; 2006 Aug; 24(8):1671-7. PubMed ID: 16877972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension.
    Leoncini G; Viazzi F; Parodi D; Vettoretti S; Ratto E; Ravera M; Tomolillo C; Del Sette M; Bezante GP; Deferrari G; Pontremoli R
    Hypertension; 2003 Jul; 42(1):14-8. PubMed ID: 12756221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microalbuminuria and cardiovascular risk assessment in primary hypertension: should threshold levels be revised?
    Ratto E; Leoncini G; Viazzi F; Vaccaro V; Parodi A; Falqui V; Bezante GP; Tomolillo C; Deferrari G; Pontremoli R
    Am J Hypertens; 2006 Jul; 19(7):728-34; discussion 735-6. PubMed ID: 16814128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of retinal vascular changes in never-treated essential hypertensives: an inter- and intra-observer reproducibility study with non-mydriatic retinography.
    Cuspidi C; Salerno M; Salerno DE; Meani S; Valerio C; Esposito A; Catini E; Magrini F; Zanchetti A
    Blood Press; 2004; 13(1):25-30. PubMed ID: 15083637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular geometry and function in patients with essential hypertension and microalbuminuria.
    Pontremoli R; Ravera M; Bezante GP; Viazzi F; Nicolella C; Berruti V; Leoncini G; Del Sette M; Brunelli C; Tomolillo C; Deferrari G
    J Hypertens; 1999 Jul; 17(7):993-1000. PubMed ID: 10419073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey.
    Cuspidi C; Ambrosioni E; Mancia G; Pessina AC; Trimarco B; Zanchetti A;
    J Hypertens; 2002 Jul; 20(7):1307-14. PubMed ID: 12131527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria.
    Cuspidi C; Meani S; Salerno M; Severgnini B; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A
    Blood Press; 2004; 13(3):144-51. PubMed ID: 15223722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of target organ damage in arterial hypertension: which role for qualitative funduscopic examination?
    Cuspidi C; Macca G; Salerno M; Michev L; Fusi V; Severgnini B; Corti C; Meani S; Magrini F; Zanchetti A
    Ital Heart J; 2001 Sep; 2(9):702-6. PubMed ID: 11666100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension.
    Leoncini G; Sacchi G; Ravera M; Viazzi F; Ratto E; Vettoretti S; Parodi D; Bezante GP; Del Sette M; Deferrari G; Pontremoli R
    J Hum Hypertens; 2002 Jun; 16(6):399-404. PubMed ID: 12037694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension.
    Leoncini G; Ratto E; Viazzi F; Vaccaro V; Parodi A; Falqui V; Conti N; Tomolillo C; Deferrari G; Pontremoli R
    Hypertension; 2006 Sep; 48(3):397-403. PubMed ID: 16880345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of cardiac and extracardiac target organ damage in refractory hypertension.
    Cuspidi C; Macca G; Sampieri L; Michev I; Salerno M; Fusi V; Severgnini B; Meani S; Magrini F; Zanchetti A
    J Hypertens; 2001 Nov; 19(11):2063-70. PubMed ID: 11677373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and correlates of advanced retinopathy in a large selected hypertensive population. The Evaluation of Target Organ Damage in Hypertension (ETODH) study.
    Cuspidi C; Meani S; Valerio C; Fusi V; Catini E; Sala C; Magrini F; Zanchetti A
    Blood Press; 2005; 14(1):25-31. PubMed ID: 15823944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum uric acid and target organ damage in essential hypertension.
    Ofori SN; Odia OJ
    Vasc Health Risk Manag; 2014; 10():253-61. PubMed ID: 24833906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.